GB virus type C/HGV markers in HCV RNA-positive French blood donors: Correlation with HCV genotypes and risk factors

Transfusion

Volumn 40, Issue 7, 2000, Pages 875-878

  Bouchardeau, F ^a,b,c,d   Laperche, S ^a,b,c,d   Pillonel, J ^a,b,c,d   Elghouzzi, M H ^a,b,c,d   Maisonneuve, P ^a,b,c,d   Tirtaine, C ^a,b,c,d   Boiret, E ^a,b,c,d   Razer, A ^a,b,c,d   Girault, A ^a,b,c,d   Beaulieu, M J ^a,b,c,d   Courouce A M ^a,b,c,d  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c Blood Transfusion Establishments of Southeast Ile de France   (France)

^d NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY DETECTION; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; GENOTYPE; HEPATITIS C VIRUS; HEPATITIS G VIRUS; HUMAN; HUMAN CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; VIRUS DETECTION; VIRUS TRANSMISSION;

BIOLOGICAL MARKERS; BLOOD DONORS; FLAVIVIRIDAE; HEPACIVIRUS; HEPATITIS C; HEPATITIS, VIRAL, HUMAN; HUMANS; RNA, VIRAL;

EID: 0033862309     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2000.40070875.x     Document Type: Article

References (21)

1. Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent
2. Identification of two flavivirus-like genomes in the GB hepatitis agent
3. Natural history of GBV-C/hepatitis G virus infection through the follow-up of GBV-C/hepatitis G virus-infected blood donors and recipients studied by RNA polymerase chain reaction and anti-E2 serology
4. Hepatitis C and G virus infection and liver dysfunction after allogenic bone marrow transplantation: Results from a prospective study
5. Prevalence of hepatitis G virus and its strain variant, the GB agent, in blood donations and their transmission to recipients
6. GBV-C/HGV: A new virus within the Flaviviridae and its clinical implications
7. Prevalence of hepatitis G virus RNA in French blood donors and recipients
8. An ELISA for detection of antibodies to the E2 protein of GB virus C
9. Detection of antibodies to a putative hepatitis G virus envelope protein
10. Expression of the GB virus C E2 glycoprotein using the Semliki Forest virus vector system and its utility as a serologic marker
11. Prevalence of GBV C/HGV RNA and GBV C/HGV antibodies in French volunteer blood donors: Results of a collaborative study
12. Hepatitis C in a French population-based survey, 1994: Seroprevalence, frequency of viremia, genotype distribution, and risk factors. The Collaborative Study Group
13. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C
14. Genotype distribution and transmission of hepatitis C virus (HCV) in French haemodialysed patients
15. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection
16. Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-α in patients with chronic hepatitis C
17. Analysis of hepatitis G virus (HGV) RNA, antibody to HGV envelope protein, and risk factors for blood donors coinfected with HGV and hepatitis C virus
18. Prevalence of GB virus type C/hepatitis G virus RNA and anti-E2 among blood donors in Southeastern France
19. High prevalence and coinfection rate of hepatitis G and C infections in intravenous drug addicts
20. Does HCV screening of blood donors affect transmission of hepatitis G virus in dialysed patients
21. Prevalence of present and past hepatitis G virus infection in a French haemodialysis centre